Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Vinorelbine × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 7 Triple Negative Breast Neoplasms 4 Rhabdomyosarcoma 4 Hodgkin Disease 4 Recurrence 3 Uterine Cervical Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Adenocarcinoma 2 Solitary Fibrous Tumor, Pleural 1 Sarcoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 NSCLC 1 Mesothelioma, Malignant 1 Lung Diseases, Interstitial 1 Locally Advanced Non-Small Cell Lung Cancer 1 HR+HER2- Breast Cancer 1 HER2-negative Metastatic Breast Cancer 1 Fludzoparib" and Anti-angiogenic 1 Desmoplastic Small Round Cell Tumor 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Large Cell 1 Advanced Breast Cancer 1

Interventions

Cyclophosphamide 11 Prednisone 8 Doxorubicin 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Vincristine 6 Azacitidine 5 fludarabine 4 Gemcitabine 4 Etoposide 4 Brentuximab Vedotin 4 romidepsin 3 belinostat 3 Dexamethasone 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 pembrolizumab 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 selinexor 1 relatlimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡